D-0372-2021 Class II Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0372-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on May 4, 2021 and is designated Class II. Reason for recall: Presence of foreign substance: identified as activated carbon. The recall status is terminated (terminated Jun 27, 2023). Affected quantity: 50868 bottles.

Recall details

Product Type
Drugs
Report Date
May 19, 2021
Initiation Date
May 4, 2021
Termination Date
Jun 27, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
50868 bottles

Product description

Metformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-142-02.

Reason for recall

Presence of foreign substance: identified as activated carbon.

Distribution pattern

USA Nationwide

Code information

Lots #: JKX2749A, JKX2803A, JKX2804A, JKX2805A, JKX806A, JKX2945A,JKX2946A, JXK2947A, JKX2948A, JKX2952A, JKX2953A, JKX2954A & JKX3224A, Exp 6/2032; JKX3211A, JKX3212A, Exp 7/2023.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0372-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0372-2021. Report a data issue: hello@regdatalab.com.